Osimertinib, EGFR-TKI, Third-generation, Irreversible, Targeted therapy for NSCLC, EGFR Ex19Del mutation, EGFR L858R mutation, CNS metastasis activity,
Sale!
Lucius
Replica: Osimertinib EGFRm NSCLC Targeted Therapy
Original price was: $705.00.$546.00Current price is: $546.00.
Osimertinib, EGFR-TKI, Third-generation, Irreversible, Targeted therapy for NSCLC, EGFR Ex19Del mutation, EGFR L858R mutation, CNS metastasis activity,